Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection

Background: Lassa virus (LASV) can cause severe acute systemic infection in humans. No approved antiviral drugs or vaccines are currently available. Antibody-based therapeutics are considered a promising treatment strategy in the management of LASV disease. Methods: We used chimeric Ifnar?/? C57B...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Oestereich, Lisa, Müller-Kräuter, Helena, Pallasch, Elisa, Strecker, Thomas
Formaat:	Artikel
Taal:	Engels
Gepubliceerd in:	Philipps-Universität Marburg 2023
Onderwerpen:	Medizin neutralizing antibodies; in vivo protection arenavirus Lassa mammarenavirus virus-like particle Lassa fever Medical sciences Medicine
Online toegang:	PDF Full text
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!